ArticleBMC gastroenterology2025
A retrospective study on the predictive value of D-dimer for mortality in patients with acute arterial occlusive mesenteric ischemia.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predictive factors for mortality in acute mesenteric ischemia.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAcute arterial occlusive mesenteric ischemia (AOMI) is a catastrophic vascular emergency associated with exceedingly high mortality rates. The lack of reliable early prognostic tools creates an urgent need for accessible biomarkers to guide management. This study aimed to evaluate mortality outcomes and assess the prognostic utility of baseline serum D-dimer levels in patients with AOMI.
methodsWe conducted a retrospective cohort study of all AOMI patients admitted to China-Japan Friendship Hospital between January 2010 and August 2024. Patients were stratified by 30-day survival status. The predictive value of serum D-dimer levels, measured within 24 h of diagnosis, for mortality was assessed using multivariate Cox regression analyses. Prognostic performance was evaluated using receiver operating characteristic (ROC) curves and Kaplan-Meier survival analysis.
resultsAmong the 61 patients included, the all-cause mortality rate was 47.5% at 30 days and 54.1% at one year. Elevated baseline D-dimer levels were independently associated with both 30-day mortality [hazard ratio (HR) 1.158, 95% confidence interval (CI) 1.080-1.243; p < 0.001] and 1-year mortality (HR 1.277, 95% CI 1.134-1.439; p < 0.001). ROC analysis indicated strong predictive accuracy, with an area under the curve (AUC) of 0.850 (95% CI 0.755-0.946) for 30-day mortality and 0.837 (95% CI 0.738-0.936) for 1-year mortality. The optimal prognostic cut-off values were 0.578 mg/L (sensitivity 82.8%, specificity 75.0%) for 30-day mortality and 0.516 mg/L (sensitivity 90.9%, specificity 60.7%) for 1-year mortality.
conclusionsAOMI continues to portend a grave prognosis. Baseline serum D-dimer level is an independent predictor of short- and long-term mortality and may serve as a practical biomarker for early risk stratification and clinical decision-making in this time-sensitive condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.